Call
Sales
866 - 285 - 7215
1-781-489-7301
Sign Up for email updates
View Cart
Press Room

FOR IMMEDIATE RELEASE

April 02, 2009
Additional Reports

U.S. MARKET FOR THERAPEUTICS AND DIAGNOSTICS FOR WOMEN’S DISORDERS WORTH $50.0 BILLION IN 2013

Wellesley, Mass—According to a new technical market research report, THERAPEUTICS AND DIAGNOSTICS FOR WOMEN’S DISORDERS (BIO043D) from BCC Research (www.bccresearch.com), the U.S. market for therapeutics and diagnostics for women’s disorders was worth almost $30.0 billion in 2008. This is expected to reach $50.0 billion in 2013, for a compound annual growth rate (CAGR) of 10.9%.
 
The market is broken down into segments for autoimmune diseases; cancer; gynecological diseases and infections; kidney and urological diseases and infections; reproductive-related therapies and diagnostics; and rheumatoid arthritis and osteoporosis. Of these, therapeutics and diagnostics for rheumatoid arthritis and osteoporosis have the largest share of the market, generating nearly $11.0 billion in 2008. This is expected to increase to $18.2 billion in 2013, for a CAGR of 11.5%.
 
Reproductive-related therapies and diagnostics currently have the second largest share of the market, worth $5.9 billion in 2008. This is expected to increase at a CAGR of 5.0% to reach $7.5 billion in 2013.
 
The application segment for cancer is the third largest market segment, generating $5.8 billion in revenues in 2008. This should increase to $11.3 billion in 2013, for a CAGR of 14.6%.
 
The dawn of a new century has ushered in an exciting and unprecedented opportunity to understand the functioning of the human body and mind. Along with rapid advancements in all medical arenas, the issue of women’s health has risen to prominence during the past two decades.
 
Women’s health and the diseases and disorders that affect women’s health have been widely recognized. Women’s health is a reflection of the overall quality of life in the United States and directly affects all other aspects of health, including men’s health and children’s health. There is now widespread recognition that the medical community, including researchers and clinicians, must understand how differences in sex and gender as well as cultural, ethnic and socioeconomic backgrounds influence the causes, diagnoses, progression and treatment of diseases.

Source: BCC Research

Therapeutics and Diagnostics for Women's Disorders( BIO043D )
Target Date: March 2009    Price: $4850.00

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC, 49 Walnut Park, Building 2, Wellesley, MA 02481, Telephone: 866-285-7215; Email: editor@bccresearch.com as the source and publisher, along with report number, which can be found in the first paragraph of this release. Thank you.